Catalyst Biosciences Inc diskutieren
Catalyst Biosciences Inc
WKN: A2DLUK / Symbol: CBIO / Name: Catalyst Bio / Aktie / Pharmazeutika / Small Cap /
0,52 €
-0,20 %
GlycoMimetics, Inc. (NASDAQ: CBIO) was upgraded by analysts at TD Cowen to a "strong-buy" rating.
Ratings data for CBIO provided by MarketBeat
GlycoMimetics, Inc. (NASDAQ: CBIO) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $28.00 price target on the stock.
Ratings data for CBIO provided by MarketBeat
Crescent Biopharma, Inc. (NASDAQ: CBIO) is now covered by analysts at Wedbush. They set an "outperform" rating and a $27.00 price target on the stock.
Ratings data for CBIO provided by MarketBeat
Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $26.00 price target on the stock.
Ratings data for CBIO provided by MarketBeat
Crescent Biopharma (NASDAQ:CBIO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
Ratings data for CBIO provided by MarketBeat
Neueste Beiträge
HC_Wainwright in InflaRx NV diskutieren